These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1625717)
21. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections. Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H; Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342 [TBL] [Abstract][Full Text] [Related]
22. [Risk of disease transmission via donor blood in Denmark at the turn of the century]. Dickmeiss E; Christiansen AH; Smith E Ugeskr Laeger; 2001 May; 163(19):2628-32. PubMed ID: 11360356 [TBL] [Abstract][Full Text] [Related]
23. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]. Contreras AM; Reta CB; Torres O; Celis A; Domínguez J Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067 [TBL] [Abstract][Full Text] [Related]
24. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia. Ben Jemia R; Gouider E Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959 [TBL] [Abstract][Full Text] [Related]
26. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
32. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling. Kleinman SH; Busch MP Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281 [TBL] [Abstract][Full Text] [Related]
33. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing]. Takahashi M; Muraoka M; Tadokoro K Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805 [No Abstract] [Full Text] [Related]
34. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)]. Pillonel J; Laperche S; ; ; Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104 [TBL] [Abstract][Full Text] [Related]
35. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529 [TBL] [Abstract][Full Text] [Related]
36. Evading bad blood. S Afr Med J; 1996 Apr; 86(4):315-6, 317. PubMed ID: 8693359 [No Abstract] [Full Text] [Related]
37. [Evaluation of risks related to blood transfusions in industrialized countries]. Salamon R; Lawson-Ayayi S; Salmi LR Rev Epidemiol Sante Publique; 1994; 42(5):408-15. PubMed ID: 7973000 [TBL] [Abstract][Full Text] [Related]
38. [Procedure of Look Back (pursuant to 19 Transfusion Law). At the 62nd meeting of the Work Group Blood on June 14, 2006 the following vote (V 34) was passed]. Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):940-57. PubMed ID: 16953363 [No Abstract] [Full Text] [Related]
39. The safety of blood components and derivatives. Julius C; Westphal RG Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072 [TBL] [Abstract][Full Text] [Related]
40. [Prevention for hepatitis C virus transmission]. Sekiguchi S Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]